Selective improvement of pulmonary arterial hypertension with a dual ETA/ETB receptors antagonist in the apolipoprotein E−/− model of PAH and atherosclerosis

Renshall, L.J., Arnold, N.D. orcid.org/0000-0002-4317-5738, West, L. et al. (10 more authors) (2018) Selective improvement of pulmonary arterial hypertension with a dual ETA/ETB receptors antagonist in the apolipoprotein E−/− model of PAH and atherosclerosis. Pulmonary Circulation , 8 (1). pp. 1-11. ISSN 2045-8932

Abstract

Metadata

Authors/Creators:
  • Renshall, L.J.
  • Arnold, N.D. https://orcid.org/0000-0002-4317-5738
  • West, L.
  • Braithwaite, A.
  • Pickworth, J.A.
  • Walker, R.
  • Alfaidi, M.A.
  • Casbolt, H.
  • Thompson, A.A.R.
  • Holt, C.
  • Iglarz, M.
  • Francis, S.
  • Lawrie, A.
Copyright, Publisher and Additional Information: © The Author(s) 2018. Creative Commons CC-BY: This article is distributed under the terms of the Creative Commons Attribution 4.0 License (http://www.creativecommons.org/licenses/by/4.0/) which permits any use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage).
Keywords: endothelin; macitentan; ApoE; pulmonary hypertension; atherosclerosis
Dates:
  • Accepted: 14 December 2017
  • Published (online): 20 December 2017
  • Published: 1 January 2018
Institution: The University of Sheffield
Academic Units: The University of Sheffield > Faculty of Medicine, Dentistry and Health (Sheffield) > Department of Cardiovascular Science (Sheffield)
Depositing User: Symplectic Sheffield
Date Deposited: 02 Jan 2018 16:05
Last Modified: 27 Aug 2019 11:53
Status: Published
Publisher: SAGE Publications
Refereed: Yes
Identification Number: https://doi.org/10.1177/2045893217752328
Related URLs:

Share / Export

Statistics